d Argyrophilic Grain Disease: Demographics, Clinical, and Neuropathological Features From a Large Autopsy Study

Imagem de Miniatura
Arquivos
art_RODRIGUEZ_d_Argyrophilic_Grain_Disease_Demographics_Clinical_and_Neuropathological_2016.PDF (167.78 KB)
Citações na Scopus
58
Tipo de produção
article
Data de publicação
2016
DOI
Scopus
Web of Science
PubMed
Título da Revista
ISSN da Revista
Título do Volume
Editora
LIPPINCOTT WILLIAMS & WILKINS
Autores
UEDA, Kenji
Citação
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, v.75, n.7, p.628-635, 2016
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Argyrophilic grain disease (AGD) is a frequent late-onset, 4 repeat tauopathy reported in Caucasians with high educational attainment. Little is known about AGD in non-Caucasians or in those with low educational attainment. We describe AGD demographics, clinical, and neuropathological features in a multiethnic cohort of 983 subjects >50 years of age from Sao Paulo, Brazil. Clinical data were collected through semistructured interviews with an informant and included in the Informant Questionnaire on Cognitive Decline in the Elderly, the Clinical Dementia Rating, and the Neuropsychiatric Inventory. Neuropathologic assessment relied on internationally accepted criteria. AGD was frequent (15.2%) and was the only neuropathological diagnosis in 8.9% of all cases (mean, 78.9 +/- 9.4 years); it rarely occurred as an isolated neuropathological finding. AGD was associated with older age, lower socioeconomic status (SES), and appetite disorders. This is the first study of demographic, clinical, and neuropathological aspects of AGD in different ethnicities and subjects from all socioeconomic strata. The results suggest that prospective studies of AGD patients include levels of hormones related to appetite control as possible antemortem markers. Moreover, understanding the mechanisms behind higher susceptibility to AGD of low SES subjects may disclose novel environmental risk factors for AGD and other neurodegenerative diseases.
Palavras-chave
Dementia, Neurodegeneration, Neuropathology, Postmortem, Tauopathy
URI
https://observatorio.fm.usp.br/handle/OPI/16083
Referências
  1. Ahima RS, 2008, ENDOCRIN METAB CLIN, V37, P811, DOI 10.1016/j.ecl.2008.08.005
  2. Almeida PM, 1991, CRITERIO ABA ABIPEME
  3. Asaoka T, 2010, PSYCHOGERIATRICS, V10, P69, DOI 10.1111/j.1479-8301.2010.00318.x
  4. Botez G, 1999, ACTA NEUROPATHOL, V98, P251
  5. BRAAK H, 1989, NEUROPATH APPL NEURO, V15, P13, DOI 10.1111/j.1365-2990.1989.tb01146.x
  6. BRAAK H, 1987, NEUROSCI LETT, V76, P124, DOI 10.1016/0304-3940(87)90204-7
  7. Braak H, 2003, NEUROBIOL AGING, V24, P197, DOI 10.1016/S0197-4580(02)00065-9
  8. Braak H, 1998, J NEURAL TRANSM, V105, P801, DOI 10.1007/s007020050096
  9. Calero O, 2009, J NEUROSCI METH, V183, P238, DOI 10.1016/j.jneumeth.2009.06.033
  10. Pham CT, 2011, NEUROBIOL AGING, V32, P1296, DOI 10.1016/j.neurobiolaging.2009.07.009
  11. Cui ZZ, 2013, J COMP NEUROL, V521, P1844, DOI 10.1002/cne.23263
  12. CUMMINGS JL, 1994, NEUROLOGY, V44, P2308
  13. Davis DG, 1999, J NEUROPATH EXP NEUR, V58, P376, DOI 10.1097/00005072-199904000-00008
  14. Ding ZT, 2006, ACTA NEUROPATHOL, V111, P320, DOI 10.1007/s00401-006-0043-2
  15. Evans DA, 1997, ARCH NEUROL-CHICAGO, V54, P1399
  16. Ferrer I, 2003, BRAIN PATHOL, V13, P62
  17. Ferrer I, 2003, ACTA NEUROPATHOL, V106, P419, DOI 10.1007/s00401-003-0756-4
  18. Ferrer I, 2008, BRAIN, V131, P1416, DOI 10.1093/brain/awm305
  19. de Lucena Ferretti RE, 2010, DEMENT NEUROPSYCOL, V2, P138
  20. Fujino Y, 2005, J NEUROPATH EXP NEUR, V64, P209
  21. Ghebremedhin E, 1998, ACTA NEUROPATHOL, V96, P222
  22. Grau-Rivera O, 2013, J NEUROL, V260, P3002, DOI 10.1007/s00415-013-7101-1
  23. Grinberg LT, 2013, CLINICS, V68, P1140, DOI 10.6061/clinics/2013(08)13
  24. Grinberg Lea Tenenholz, 2007, Cell and Tissue Banking, V8, P151, DOI 10.1007/s10561-006-9022-z
  25. Grinberg LT, 2013, ACTA NEUROPATHOL, V125, P581, DOI 10.1007/s00401-013-1080-2
  26. Ikeda K, 2000, CLIN NEUROPATHOL, V19, P278
  27. Ishihara K, 2005, NEUROPATHOLOGY, V25, P165, DOI 10.1111/j.1440-1789.2005.00598.x
  28. Ishizawa T, 2002, J NEUROPATH EXP NEUR, V61, P1040
  29. Jicha GA, 2006, J NEUROPATH EXP NEUR, V65, P602, DOI 10.1097/01.jnen.0000225312.11858.57
  30. JORM AF, 1994, PSYCHOL MED, V24, P145
  31. Josephs KA, 2008, NEUROBIOL AGING, V29, P566, DOI 10.1016/j.neurobiolaging.2006.10.032
  32. Kawashima T, 1999, PATHOL INT, V49, P369, DOI 10.1046/j.1440-1827.1999.00883.x
  33. Knopman DS, 2003, J NEUROPATH EXP NEUR, V62, P1087
  34. Kovacs GG, 2008, ACTA NEUROPATHOL, V116, P103, DOI 10.1007/s00401-007-0322-6
  35. Larson EB, 2013, NEW ENGL J MED, V369, P2275, DOI 10.1056/NEJMp1311405
  36. Lein ES, 2005, J COMP NEUROL, V485, P1, DOI 10.1002/cne.20426
  37. Mackenzie IRA, 2010, ACTA NEUROPATHOL, V119, P1, DOI 10.1007/s00401-009-0612-2
  38. MartinezLage P, 1997, J NEUROPATH EXP NEUR, V56, P157, DOI 10.1097/00005072-199702000-00006
  39. MASLIAH E, 1991, ANN NEUROL, V29, P389, DOI 10.1002/ana.410290409
  40. Maurage CA, 2003, ACTA NEUROPATHOL, V106, P575, DOI 10.1007/s00401-003-0762-6
  41. Miserez AR, 2003, ACTA NEUROPATHOL, V106, P363, DOI 10.1007/s00401-003-0742-x
  42. Montine TJ, 2012, ACTA NEUROPATHOL, V123, P1, DOI 10.1007/s00401-011-0910-3
  43. MORRIS JC, 1993, NEUROLOGY, V43, P2412
  44. Nagao S, 2014, EUR ARCH PSY CLIN N, V264, P317, DOI 10.1007/s00406-013-0472-6
  45. Nitrini R, 2004, ALZ DIS ASSOC DIS, V18, P241
  46. Rodriguez Roberta Diehl, 2015, Dement. neuropsychol., V9, P2, DOI 10.1590/S1980-57642015DN91000002
  47. Ronnback A, 2014, ACTA NEUROPATHOL, V127, P297, DOI 10.1007/s00401-013-1229-z
  48. Sabbagh MN, 2009, ALZ DIS ASSOC DIS, V23, P229, DOI 10.1097/WAD.0b013e318199d833
  49. Saito Y, 2002, J NEUROPATH EXP NEUR, V61, P789
  50. Saito Y, 2004, J NEUROPATH EXP NEUR, V63, P911
  51. Saito Y, 2007, NEUROPATHOLOGY, V27, P578, DOI 10.1111/j.1440-1789.2007.00806.x
  52. Sattler C, 2012, PSYCHIAT RES, V196, P90, DOI 10.1016/j.psychres.2011.11.012
  53. Schultz C, 1998, ACTA NEUROPATHOL, V96, P596
  54. Seno H, 2000, J NEUROL SCI, V178, P70, DOI 10.1016/S0022-510X(00)00359-2
  55. Steuerwald GM, 2007, DEMENT GERIATR COGN, V24, P229, DOI 10.1159/000107085
  56. Loane DJ, 2014, J NEUROPATH EXP NEUR, V73, P14, DOI [10.1097/NEN.0000000000000022, 10.1097/NEN.0000000000000021]
  57. Thal DR, 2008, ACTA NEUROPATHOL, V115, P175, DOI 10.1007/s00401-007-0330-6
  58. Thal DR, 2005, NEUROPATH APPL NEURO, V31, P270, DOI 10.1111/j.1365-2990.2004.00635.x
  59. Thal DR, 2002, NEUROLOGY, V58, P1791
  60. Togo T, 2002, ACTA NEUROPATHOL, V104, P53, DOI 10.1007/s00401-002-0520-1
  61. Togo T, 2002, BRAIN PATHOL, V12, P45
  62. Togo T, 2005, AM J GERIAT PSYCHIAT, V13, P1083, DOI 10.1176/appi.ajgp.13.12.1083
  63. Tolnay M, 1998, ACTA NEUROPATHOL, V96, P225
  64. Tolnay M, 1998, NEUROPATH APPL NEURO, V24, P53
  65. Tolnay M, 2004, NEUROPATHOLOGY, V24, P269, DOI 10.1111/j.1440-1789.2004.00591.x
  66. Tolnay M, 1997, ACTA NEUROPATHOL, V93, P477
  67. Tolnay M, 2002, ACTA NEUROPATHOL, V104, P425, DOI 10.1007/s00401-002-0591-z
  68. Tolnay M, 1998, NEUROSCI LETT, V246, P165, DOI 10.1016/S0304-3940(98)00250-X
  69. Tolnay M, 1997, ACTA NEUROPATHOL, V94, P353
  70. Villela D, 2013, GENET MOL BIOL, V4, P498

Coleções
Artigos e Materiais de Revistas Científicas - FM/MCM
Artigos e Materiais de Revistas Científicas - FM/MNE
Artigos e Materiais de Revistas Científicas - FM/MPT
Artigos e Materiais de Revistas Científicas - HC/ICHC
Artigos e Materiais de Revistas Científicas - LIM/15
Artigos e Materiais de Revistas Científicas - LIM/22